Brain and spinal cord abnormalities in multiple sclerosis. Correlation between MRI parameters, clinical subtypes and symptoms.
about
Magnetic resonance spectroscopic findings of chronic lesions in two subtypes of multiple sclerosis: primary progressive versus relapsing remittingImaging neuroinflammation in multiple sclerosis using TSPO-PETClinico-pathological evidence that axonal loss underlies disability in progressive multiple sclerosisCharacterization of tissue damage in multiple sclerosis by nuclear magnetic resonance.Adaptive functional changes in the cerebral cortex of patients with nondisabling multiple sclerosis correlate with the extent of brain structural damage.Clinical, MRI, and CSF markers of disability progression in multiple sclerosis.Issues and practices in multiple sclerosis.Imaging primary progressive multiple sclerosis: the contribution of structural, metabolic, and functional MRI techniques.Spinal cord MRI in multiple sclerosis--diagnostic, prognostic and clinical value.Biomarkers and surrogate outcomes in neurodegenerative disease: lessons from multiple sclerosis.Imaging spinal cord damage in multiple sclerosis.Clinical-magnetic resonance imaging correlations in multiple sclerosis.MRI in multiple sclerosis: what's inside the toolbox?The clinical utility of QSM: disease diagnosis, medical management, and surgical planning.Axial diffusivity is the primary correlate of axonal injury in the experimental autoimmune encephalomyelitis spinal cord: a quantitative pixelwise analysisMultiple sclerosis lesions: insights from imaging techniques.Two-year study of cervical cord volume and myelin water in primary progressive multiple sclerosis.The effect of hypointense white matter lesions on automated gray matter segmentation in multiple sclerosis.Axonal loss results in spinal cord atrophy, electrophysiological abnormalities and neurological deficits following demyelination in a chronic inflammatory model of multiple sclerosisQuantitation of spinal cord demyelination, remyelination, atrophy, and axonal loss in a model of progressive neurologic injury.Spinal Cord as an Adjunct to Brain Magnetic Resonance Imaging in Defining "No Evidence of Disease Activity" in Multiple Sclerosis.Asymptomatic spinal cord lesions predict disease progression in radiologically isolated syndromeProgressive multiple sclerosis and gray matter pathology: an MRI perspective.Spontaneous ocular and neurologic deficits in transgenic mouse models of multiple sclerosis and noninvasive investigative modalities: a reviewT2 lesion location really matters: a 10 year follow-up study in primary progressive multiple sclerosis.The role of immune cells, glia and neurons in white and gray matter pathology in multiple sclerosis.Benign multiple sclerosis: does it exist?Radial diffusivity predicts demyelination in ex vivo multiple sclerosis spinal cords.Cervical spinal cord multiple sclerosis: evaluation with 2D multi-echo recombined gradient echo MR imaging.Optimized T1-MPRAGE sequence for better visualization of spinal cord multiple sclerosis lesions at 3TUsing diffusion tensor imaging and immunofluorescent assay to evaluate the pathology of multiple sclerosis.Feasibility of imaging myelin lesions in multiple sclerosisNew approaches to investigating heterogeneity in complex traitsThree dimensional MRI estimates of brain and spinal cord atrophy in multiple sclerosis.Relative contributions of brain and cervical cord pathology to multiple sclerosis disability: a study with magnetisation transfer ratio histogram analysisSpinal cord atrophy and disability in multiple sclerosis over four years: application of a reproducible automated technique in monitoring disease progression in a cohort of the interferon beta-1a (Rebif) treatment trial.Increasing cord atrophy in early relapsing-remitting multiple sclerosis: a 3 year studyNovel composite MRI scale correlates highly with disability in multiple sclerosis patients.Segmented corpus callosum diffusivity correlates with the Expanded Disability Status Scale score in the early stages of relapsing-remitting multiple sclerosisSpinal cord lesions and clinical status in multiple sclerosis: A 1.5 T and 3 T MRI study
P2860
Q24630939-876608F9-2A1E-4C28-B57C-52E1C6D7C6E4Q28084625-AE787ABE-9302-4C91-82B5-6DC5E05BF707Q28275482-C3081432-5847-4744-A0AC-D99B1C4348BBQ30585635-749A1FB5-079B-45F7-A20C-34AD83DF87A3Q30679381-71079E27-A8B3-4FB7-A78D-1EBF1979D5B7Q30712257-AF932540-F180-4853-B587-F1D3701EFA6FQ30751454-0063CD70-073C-485E-AB5C-3BA9198DF983Q30940046-CC2C9CC9-EE58-44E0-9F56-E5843E494380Q30958322-33B2FB9B-6D57-4151-9D15-2348E89231FDQ30983016-1731E112-5CF7-47F4-8D9B-7B1EC7641253Q31013847-27C1001C-EC74-4D89-8B51-5F8C459EAF9AQ31027945-7473EEFB-9D81-4F13-8DD6-21E6B93DC27EQ31132442-65DEC1EF-93D0-431F-B4AD-8A64D747321FQ31146333-00FB02CA-BF4E-45F5-9AB7-CDB4467E14A1Q33414966-6706C4F6-1DC0-43D9-BC08-FCECCBB831BCQ33505423-4F34B6C8-693A-42F1-9C58-BEF20B7ADE7EQ33608445-D86C1D59-13FC-412A-9FD9-2AC2D9FF6E35Q33698702-D8F3FA59-9F69-433F-8B59-A84226C2A4B5Q33727379-BCF894A3-FF5F-4E64-BFDF-9543915F115BQ33746036-9949BED6-2FF6-4E8E-89D5-822F537C8A55Q33769234-C80EEE62-C765-4707-ABFE-7F1837BD3BA9Q33804832-2FD70664-6842-415A-8DDD-86BCF7FE22A7Q33852170-35485E23-7AD3-4123-8C04-1654FD28AD16Q34158137-616E1965-A765-426C-B24B-D3FB46D122AEQ34410090-900080F9-F92A-46ED-BFF3-6DC2AA42ACCAQ34468304-8459EE2E-EFA5-4379-BC66-DDD7FFA486EDQ34640135-FCDA2B09-503B-4CE1-9F9D-51108C8D93AEQ34709354-4433D36E-3580-45DF-8D86-3FE2502041D3Q34734421-58AD7262-5017-42CF-AA8A-3BCC5D6A0358Q34781818-EF834EEC-0032-41BF-A420-B00CFB41DBCCQ34823496-BCB2B520-E323-4EDA-9DE3-2550F2AF3643Q35168009-FDBC9FD9-4BBC-44B7-8DE5-B9DEFEAD5EA3Q35200318-BFA55B6D-A403-4325-B768-2AA9878BD745Q35450216-93EB9722-E7F8-4167-B25F-12EA6A7A025CQ35459896-F6EBD15C-6530-42D2-AE2D-1CF95592AEEBQ35475689-27E101D5-56DE-4E4D-A5F2-4AE830381EF0Q36226297-9E3B834A-239F-408C-8F3E-D74647EBAD36Q36307718-4EF1A1A2-B56B-408B-BEFD-A5CC766E3104Q37119047-3F7A6A13-1AF9-40D8-AAA3-CD567182511FQ37185718-D8A2B8AB-A9FB-4027-828A-CC410172604F
P2860
Brain and spinal cord abnormalities in multiple sclerosis. Correlation between MRI parameters, clinical subtypes and symptoms.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh-hant
name
Brain and spinal cord abnormal ...... linical subtypes and symptoms.
@en
Brain and spinal cord abnormal ...... linical subtypes and symptoms.
@nl
type
label
Brain and spinal cord abnormal ...... linical subtypes and symptoms.
@en
Brain and spinal cord abnormal ...... linical subtypes and symptoms.
@nl
prefLabel
Brain and spinal cord abnormal ...... linical subtypes and symptoms.
@en
Brain and spinal cord abnormal ...... linical subtypes and symptoms.
@nl
P2093
P356
P1433
P1476
Brain and spinal cord abnormal ...... linical subtypes and symptoms.
@en
P2093
Castelijns JA
Nijeholt GJ
Scheltens P
van Waesberghe JH
van Walderveen MA
P304
P356
10.1093/BRAIN/121.4.687
P407
P478
121 ( Pt 4)
P50
P577
1998-04-01T00:00:00Z